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Little is known about optimal screening processes for brief
intervention (BI) targeting substances other than alcohol
and nicotine. An ongoing multi-site trial conducted
through the National Institute on Drug Abuse-Clinical
Trials Network (NIDA-CTN) investigates the effectiveness
of BI for people who use drugs (with or without alcohol
use) presenting to medical emergency departments (EDs).
Here we describe the screening procedures and present
preliminary data on the screening process and characteris-
tics of participants enrolled in the trial. Following triage,
patients are selected through ED tracking logs, and demo-
graphic information, triage level, and presenting complaint
are recorded. Patients are then invited to complete screen-
ing with an instrument including four tobacco screening
questions, the three consumption questions of the Alcohol
Use Disorders Identification Test (AUDIT-C), and the
10-item Drug Abuse Screening Test (DAST). A DAST
score of three or more plus past 30-day use of the primary
problem substance are required for enrollment. During the
first six months of recruitment, a total of 5713 patients
were selected for possible screening; 3731 completed
screening, and 343 were randomized (6% of all selected).
The sample is 64% male with a mean age of 39 (± 12), and
is racially and ethnically diverse. Only 2% are college gradu-
ates, 9% are married, 10% have full-time jobs, and 79% have
household incomes under $15,000. The most common pri-
mary drugs of abuse were cannabis (33%, used on an aver-
age of 18 out of the past 30 days), cocaine (26%, use on and
average of 9 of the past 30 days), street opioids (26%, used
on an average of 19 of the past 30 days), prescription
opioids (6%, used on an average of 18 of the past 30 days),
and methamphetamine (6%, used on an average of 7 of the
past 30 days). Six percent of those selected for screening
and 9% of those screened were enrolled in the study. Base-
line data indicate that the screening procedures identified
people with problems in multiple life domains who had
heavy use of several types of drugs.
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